immutep (asx:imm) sitc 2021 results - management update
Published 2 years ago • 56 plays • Length 1:14:06Download video MP4
Download video MP3
Similar videos
-
1:14:06
immutep webinar - sitc 2021 results - 17 november 2021
-
52:08
immutep (asx:imm) - update on tacti-002 phase ii and insight-003 phase 1 data presented at sitc 2022
-
7:43
immutep (asx:imm) company update on start of 2021
-
16:06
immutep (asx:imm) - webinar presentation
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
6:09
comptia network cert ; n10 006 icmp and igmp
-
7:13
from the helm: immutep's (asx:imm) executive director & ceo marc voigt
-
4:06
immutep (asx:imm) 1h19 results and outlook
-
1:12:13
immutep tacti-002 and insight clinical results & update
-
4:32
immutep (asx:imm) company update
-
5:17
immutep (asx:imm) clinical trial update and partnerships
-
4:54
immutep (asx:imm) 1h20 results & outlook
-
7:17
immutep (asx:imm) delivering strong data in first-line non-small cell lung cancer
-
7:43
immutep (asx:imm; nasdaq: immp) company update on start of 2021
-
4:19
immutep (asx:imm) clinical trial update
-
12:28
clinical trials in cancer and autoimmune diseases: immutep's ceo marc voigt provides an update
-
15:49
immutep (asx:imm) - webinar presentation
-
5:20
immutep (asx:imm) fy18 results
-
16:07
immutep (asx:imm) - webinar presentation
-
5:00
tacti 002 hnscc sitc 2021 - abstract # 359
-
50:22
immutep (asx:imm) esmo congress results webinar, october 2023